Cost-Effectiveness Analysis of Temsirolimus in Patientswith Poor Risk Renal-Cell Carcinoma
碩士 === 臺北醫學大學 === 醫務管理學研究所 === 98 === Background: Renal cell carcinoma is a type of kidney cancer. One fourth of patients present with advanced disease, including locally invasive or metastatic RCC. The mainstay of systemic therapy for RCC has historically been immunotherapy with interferon-a in the...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2010
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/06220171622667834278 |